Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
$0.47
Last Updated: Mar 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Shenzhen Hepalink Pharmaceutical Group Co Ltd. Stock Analysis SHEZF
United States Health Care Mid Cap Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 2,150 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.
Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF) Chart
Financial Metrics & Statements of Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF)
FAQ's for Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF)
- As of August 2026, Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shenzhen Hepalink Pharmaceutical Group Co Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Shenzhen Hepalink Pharmaceutical Group Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Shenzhen Hepalink Pharmaceutical Group Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Shenzhen Hepalink Pharmaceutical Group Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Shenzhen Hepalink Pharmaceutical Group Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Shenzhen Hepalink Pharmaceutical Group Co Ltd (SHEZF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
